PRTA
Price:
$8.56
Market Cap:
$448.14M
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline includes Prasinezumab, an investigational humanized monoclonal antibody which is in Phase 3 clinical trial for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in Phase 3 clinical trial for the treatment of transthyretin amyloidosis; BMS-986446, an anti-tau antibody which is in Phase 2 clinical trial to treat Alzheimer's disease; PRX019, an investigational antibody which is in Phase 1 clinical trial for th...[Read more]
Industry
Biotechnology
IPO Date
2012-12-20
Stock Exchange
NASDAQ
Ticker
PRTA
According to Prothena Corporation plc’s latest financial reports and current stock price. The company's current PE Ratio is -3.49. This represents a change of 124.37% compared to the average of -1.56 of the last 4 quarters.
The mean historical PE Ratio of Prothena Corporation plc over the last ten years is -4.79. The current -3.49 PE Ratio has changed 7.19% with respect to the historical average. Over the past ten years (40 quarters), PRTA's PE Ratio was at its highest in in the December 2022 quarter at 115.87. The PE Ratio was at its lowest in in the June 2017 quarter at -29.41.
Average
-4.79
Median
-7.11
Minimum
-24.39
Maximum
32.72
Discovering the peaks and valleys of Prothena Corporation plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 209.74%
Maximum Annual PE Ratio = 32.72
Minimum Annual Increase = -857.27%
Minimum Annual PE Ratio = -24.39
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.11 | -65.45% |
| 2024 | -6.10 | -53.66% |
| 2023 | -13.17 | -46.02% |
| 2022 | -24.39 | -174.56% |
| 2021 | 32.72 | -857.27% |
| 2020 | -4.32 | -46.78% |
| 2019 | -8.12 | 209.74% |
| 2018 | -2.62 | -71.55% |
| 2017 | -9.21 | -12.74% |
| 2016 | -10.56 | -58.77% |
The current PE Ratio of Prothena Corporation plc (PRTA) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.13
5-year avg
-2.61
10-year avg
-4.79
Prothena Corporation plc’s PE Ratio is greater than KalVista Pharmaceuticals, Inc. (-8.36), less than Bicycle Therapeutics plc (-1.23), greater than 4D Molecular Therapeutics, Inc. (-3.61), less than Verastem, Inc. (-2.40), greater than Olema Pharmaceuticals, Inc. (-5.54), greater than Ventyx Biosciences, Inc. (-12.84), less than Neumora Therapeutics, Inc. Common Stock (-1.24), greater than Corvus Pharmaceuticals, Inc. (-23.71), less than Gossamer Bio, Inc. (-0.26), less than Rigel Pharmaceuticals, Inc. (1.95),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.36 | $1.44B | |
| -1.23 | $267.86M | |
| -3.61 | $502.37M | |
| -2.40 | $528.12M | |
| -5.54 | $977.42M | |
| -12.84 | $1.00B | |
| -1.24 | $305.72M | |
| -23.71 | $1.10B | |
| -0.26 | $48.48M | |
| 1.95 | $722.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prothena Corporation plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prothena Corporation plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Prothena Corporation plc's PE Ratio?
How is the PE Ratio calculated for Prothena Corporation plc (PRTA)?
What is the highest PE Ratio for Prothena Corporation plc (PRTA)?
What is the 3-year average PE Ratio for Prothena Corporation plc (PRTA)?
What is the 5-year average PE Ratio for Prothena Corporation plc (PRTA)?
How does the current PE Ratio for Prothena Corporation plc (PRTA) compare to its historical average?